Summary. Experiments were designed to determine whether pmsg is essential for the continued maturation of follicles whose initial development is stimulated by the hormone in immature mice. Anti-pmsg serum (aps), prepared in rabbits, was used at various times after pretreatment with pmsg to determine the time required for pmsg to mature follicles. Follicular maturity was tested by the ovulatory response to hcg.
INTRODUCTION
Ovulation is readily induced in immature mice and rats by the consecutive administration of pmsg and hcg. The optimum interval between pmsg and hcg is 54 to 56 hr (Rowlands, 1944; Runner & Palm, 1953; Zarrow, Caldwell, Hafez & Pincus, 1958; Sasamoto & Murakami, 1961b; Wilson & Zarrow, 1962) . When hcg administration is delayed until 72 hr after pretreatment with 2-5 i.u. pmsg, ovulation in immature mice does not occur regularly, even with a large amount of hcg. Histologically, follicles appear to begin to degenerate 72 hr after treatment with 2-5 i.u. pmsg (Imai, Sasamoto & Suzuki, 1965) .
The present paper is primarily concerned with the time at which pmsg must be present in the circulating blood for follicles to 
MATERIALS AND METHODS
Immature female mice, aged 20 to 25 days and weighing 7-0 to 9-5 g at the beginning of the experiment, were obtained commercially and randomly allotted to the treatment groups.
An injection of 2300 i.u. PMSG/mg was used to stimulate follicle growth and of 2200 i.u. HCG/mg to induce ovulation. All injections were given in a total volume of 0-1 ml 0-9% NaCl. The mice were killed with chloroform 20 to 24 hr after the hcg injection to examine for the presence of tubai ova by the method of Burdick & Whitney (1941 (Sasamoto, 1962 (Sasamoto, , 1969 Three units of aps-4 were given simultaneously with 3 i.u. pretreatment pmsg to check the activity of aps by ovarian and uterine weight methods. The results (Table 2) indicate that no significant increases were observed in the ovarian or uterine weights of the aps-and PMSG-treated group as compared with those of the saline-treated group. The inhibition of the ovarian or uterine weight increase in the aps-and PMSG-treated group was highly significant as compared with that of the group treated with 3 i.u. pmsg. Table 3 .
When aps and hcg were given 60 hr after pretreatment with pmsg, maximum ovulation was obtained (Group I) ; no inhibitory effect of aps on the ovulating activity of hcg was observed for the level of aps used in this experiment. When aps and hcg were injected 54 hr after pmsg, 94% of the mice ovulated with no significant difference from that of the maximum ovulation group (Group IV-a). Table 3 effect on hcg-induced ovulation of anti-pmsg serum given at dif¬ ferent times after pretreatment with pmsg in immature mice fig. 1 ).
The percentages of mice ovulating were transformed to probits against the doses of hcg on a log scale. The results were computed as a parallel line assay by the method of Finney (1964) . In the following computations, the results with 0-27, 0-4 and 0-6 i.u. hcg were used. In the group injected with supplementary pmsg, no significant departure from linearity or parallelism was noted. The results gave a potency of (Table  3 , Group IV-b). Perhaps, due to the deficiency of circulating pmsg during the last 6 hr, mature follicles may begin to degenerate and lose their ability to ovulate. Talbert, Meyer & McShan (1951) reported that the maturing follicles of the rat lose their ability to ovulate by 8 to 12 hr following hypophysectomy at the pro-oestrous stage. Eto & Imamichi (1955) also observed that in dioestrous rats, follicles lost their ability to ovulate 10 hr after hypophysectomy. In the present experiment using intact immature mice, complete inhibition of ovula¬ tion was observed in the group given aps 24 hr before hcg but not in the group given aps 12 hr before hcg. These differences may be due to the presence of endogenous circulating gonadotrophins in immature mice. Sasamoto (1962) reported that the half-life of pmsg in mice is 6 hr. (1965) observed that the follicles of immature mice began to show pycnosis of the granulosa cells 72 hr after pretreatment with 2-5 i.u. pmsg. In normal cyclic female rats, however, mature follicles were still capable of ovulation when ovulating hormone release was inhibited on 2 successive days (Everett & Sawyer, 1950) , but showed atresia following inhibition on 3 successive days. These results indicate that the ovulating capacity of mature follicles can be main¬ tained for 48 hr. Freeman, Butcher & Fugo (1970) (Imai, Nishino & Sasamoto, 1960; Sasamoto & Murakami, 1961a The optimum amount of pmsg required for the development of secondary follicles into mature follicles was estimated as 2-5 to 3 i.u. (Sasamoto & Mura¬ kami, 1961a; Imai etal, 1965 (Imai et al, 1960) . In these two experiments, the difference in the optimal interval between pmsg and hcg injections may be due to the different stages of follicular development in the ovaries of mice at the time of pmsg administration. From the follicular development and maintenance in immature mice by the optimal amount of pmsg, it is concluded that the biological active life of pmsg is 54 to 60 hr. After that, the amount of circulating pmsg decreases below the threshold level necessary for the functional maintenance of mature follicles, although a small amount of endogenous gonadotrophin may exist.
Supplementary administration of 0-25 i.u. pmsg 58 hr after pretreatment had little influence on the induction of ovulation by hcg 54 hr after pmsg pretreat¬ ment (Table 4 , Group Il-a versus Group I-a). Pregnant mares' serum gonado¬ trophin can induce ovulation when given in a dose of more than 1 i.u. sub¬ cutaneously or 0-45 i.u. intravenously (Sasamoto, 1962) . In the present experi¬ ments, supplementary pmsg was given 4 hr after the ovulating hcg, when mature follicles had probably been destined to ovulate (Sasamoto, 1969 (Sasamoto, , 1970 . The other follicles which did not ovulate following injection of hcg were assumed to be too small to respond to the 0-25 i.u. pmsg supplement. When hcg and pmsg, as ovulating hormones, were injected simultaneously, no augmenting effect on the induction of ovulation was observed by Wells, Khosla & Brown (1964) .
